Skip to main content
. 2017 Nov 14;12(11):e0187792. doi: 10.1371/journal.pone.0187792

Fig 3. Forest plot on a log scale of the Odds ratios between dalbavancin and all other treatments for discontinuation due to AEs/SAEs for adults only (Odds ratio >1 favours DAL).

Fig 3